TG Therapeutics Competitors
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside | Analysts | Market Cap |
|---|---|---|---|---|---|---|---|---|---|
| NOVN | Novartis | Hold |
10
|
CHF93.37 | Buy/Sell | CHF105.00 | 15.26% | 9 | CHF190.51B |
| SAN | Sanofi | Outperform |
16
|
89.17€ | Buy/Sell | 102.80€ | 22.80% | 9 | 111.47€B |
| BMY | Bristol-Myers Squibb | Hold |
2
|
$44.03 | Buy/Sell | $58.15 | 22.64% | 10 | $89.25B |
| MRK | Merck KGaA | Outperform |
18
|
167.20€ | Buy/Sell | 190.06€ | 6.46% | 4 | 72.69€B |
| BIIB | Biogen | Outperform |
10
|
$230.57 | Buy/Sell | $299.62 | 25.12% | 13 | $33.57B |
| BAYN | Bayer | Hold |
5
|
28.58€ | Buy/Sell | 45.15€ | 4.97% | 4 | 28.08€B |
| GMAB | Genmab A/S | Outperform |
16
|
kr2.04k | Buy/Sell | kr2.71k | 29.35% | 14 | kr131.83B |
| TEVA | Teva Pharmaceutical Industries | Outperform |
12
|
$16.29 | Buy/Sell | $11.59 | 4.36% | 9 | $18.45B |
| ALKS | Alkermes | Outperform |
10
|
$24.15 | Buy/Sell | $33.27 | 32.51% | 3 | $4.11B |